USPTO serial 79021892
Serial No. 79021892
Reviewed by CopyMark Law Group
Status 402
- Filing date
- Status date
- Registration date
- —
- Examiner
- BRODY, DANIEL S
- Law office
- TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79021892?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | 1. Ointments (used for skin diseases) 2. Chemical-Pharmaceutical Preparations(used for anesthetic recovery, fever relief, anti- inflammation, gout, rheumatoid disease,anti-anaphylaxis, anaphylaxis, detoxification, poisoning treatment, anti-convulsion,anti-epilepsy, anti-infection, anti-migraine, anti-tumor, immune suppression, palliative treatment, anti-parkinsonism, blood diseases, cardiovascular diseases, skin diseases, diuresis,gastrointestinal diseases, digestive system diseases, hormone therapy and other endocrine diseases, contraception, immune diseases, ophthalmic diseases, mental diseases, respiratory diseases, replenishment of vitamins, minerals and other nutrition, anti-parasite, anti-malaria and malarial treatment as well as used as raw material medicines of the above drugs, medical solvents and anesthesia agents) 3. Medicines for Human Purposes (used for anesthetic recovery, fever relief, anti- inflammation, gout, rheumatoid disease, anti-anaphylaxis,anaphylaxis, detoxification, poisoning treatment, anti-convulsion, anti-epilepsy, anti-infection,anti-migraine, anti-tumor, immune suppression, palliative treatment, anti-parkinsonism, blood diseases, cardiovascular diseases, skin diseases, gastrointestinal diseases, digestive system diseases, hormone therapy and other endocrine diseases, contraception, immune diseases,respiratory diseases, replenishment of vitamins, minerals and other nutrition, anti-parasite,malarial diseases as well as used in analgesics and Chinese drugs for gastrointestinal diseases, digestive system diseases, endocrine diseases, anti-tumor, anti-malaria and cardiovascular diseases) 4. Surgical Dressings (medical supplies and bandages for burn and surgeries) 5. Antisepsis Paper 6. Teeth Filling Materials 7. Medicinal Drinks 8. Medical Tapes 9. Medical Nourishments 10. Solutions for Contact Lens | SECTION 70 - CANCELLED | — |
| 040 | 1. Medicinal Materials Processing (Chinese drug production and processing including selection, slicing, steaming, soaking and subpackage of medicinal materials) 2. Chemistry Reagent Processing and Management (used for preparation, production and application guidance of PCRagents for sample testing such as serum, sputum and secretions as well as for preparation,production and application guidance of biochemical agents for sample testing such as bloods and body fluids) | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 22, 2016 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Apr 21, 2016 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Apr 23, 2009 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 1, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 1, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 1, 2008 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 1, 2008 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 12, 2007 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 12, 2007 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 27, 2007 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 27, 2007 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 24, 2007 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 23, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 23, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 23, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 4, 2006 | ALIE | ASSIGNED TO LIE | — |
| Oct 5, 2006 | PAPER RECEIVED | — | |
| May 18, 2006 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 3, 2006 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 3, 2006 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 2, 2006 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 1, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 28, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 28, 2006 | NWAP | NEW APPLICATION ENTERED | — |
| Apr 27, 2006 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |